Literature DB >> 11602765

N-terminal cleavage fragment of glycosylated Gag is incorporated into murine oncornavirus particles.

R Fujisawa1, F J McAtee, C Favara, S F Hayes, J L Portis.   

Abstract

Glycosylated Gag (Glycogag) is a transmembrane protein encoded by murine and feline oncornaviruses. While the protein is dispensible for virus replication, Glycogag-null mutants of a neurovirulent murine oncornavirus are slow to spread in vivo and exhibit a loss of pathogenicity. The function of this protein in the virus life cycle, however, is not understood. Glycogag is expressed at the plasma membrane of infected cells but has not been detected in virions. In the present study we have reexamined this issue and have found an N-terminal cleavage fragment of Glycogag which was pelleted by high-speed centrifugation and sedimented in sucrose density gradients at the same bouyant density as virus particles. Its association with virions was confirmed by velocity sedimentation through iodixanol, which effectively separated membrane microvesicles from virus particles. Furthermore, the apparent molecular weight of the virion-associated protein was different from that of the protein extracted from the plasma membrane, suggesting some level of specificity or selectivity of incorporation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11602765      PMCID: PMC114705          DOI: 10.1128/JVI.75.22.11239-11243.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  22 in total

1.  Characterization of glycosylated Gag expressed by a neurovirulent murine leukemia virus: identification of differences in processing in vitro and in vivo.

Authors:  R Fujisawa; F J McAtee; J H Zirbel; J L Portis
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

2.  Cellular proteins in HIV virions.

Authors: 
Journal:  Rev Med Virol       Date:  1997-09       Impact factor: 6.989

3.  Polypeptides of feline leukemia virus: a glycosylated gag-related protein is released into culture fluids.

Authors:  J C Neil; J E Smart; M J Hayman; O Jarrett
Journal:  Virology       Date:  1980-08       Impact factor: 3.616

4.  Deletion mutants of Moloney murine leukemia virus which lack glycosylated gag protein are replication competent.

Authors:  P Schwartzberg; J Colicelli; S P Goff
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

5.  Post-translational modification of Rauscher leukemia virus precursor polyproteins encoded by the gag gene.

Authors:  A M Schultz; E H Rabin; S Oroszlan
Journal:  J Virol       Date:  1979-04       Impact factor: 5.103

6.  CUG initiation codon used for the synthesis of a cell surface antigen coded by the murine leukemia virus.

Authors:  A C Prats; G De Billy; P Wang; J L Darlix
Journal:  J Mol Biol       Date:  1989-01-20       Impact factor: 5.469

7.  Identification of a sequence in the unique 5' open reading frame of the gene encoding glycosylated Gag which influences the incubation period of neurodegenerative disease induced by a murine retrovirus.

Authors:  J L Portis; G J Spangrude; F J McAtee
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

8.  A nonstructural gag-encoded glycoprotein precursor is necessary for efficient spreading and pathogenesis of murine leukemia viruses.

Authors:  A Corbin; A C Prats; J L Darlix; M Sitbon
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

9.  Construction and characterization of Moloney murine leukemia virus mutants unable to synthesize glycosylated gag polyprotein.

Authors:  H Fan; H Chute; E Chao; M Feuerman
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

10.  gag-Related polyproteins of Moloney murine leukemia virus: evidence for independent synthesis of glycosylated and unglycosylated forms.

Authors:  S A Edwards; H Fan
Journal:  J Virol       Date:  1979-05       Impact factor: 5.103

View more
  15 in total

1.  Essential role for virus-neutralizing antibodies in sterilizing immunity against Friend retrovirus infection.

Authors:  Ronald J Messer; Ulf Dittmer; Karin E Peterson; Kim J Hasenkrug
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-05       Impact factor: 11.205

2.  Mouse retroviruses and chronic fatigue syndrome: Does X (or P) mark the spot?

Authors:  Valerie Courgnaud; Jean-Luc Battini; Marc Sitbon; Andrew L Mason
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-23       Impact factor: 11.205

3.  Intact Viral Particle Counts Measured by Flow Virometry Provide Insight into the Infectivity and Genome Packaging Efficiency of Moloney Murine Leukemia Virus.

Authors:  Tyler Milston Renner; Vera A Tang; Dylan Burger; Marc-André Langlois
Journal:  J Virol       Date:  2020-01-06       Impact factor: 5.103

4.  Deaminase-Dead Mouse APOBEC3 Is an In Vivo Retroviral Restriction Factor.

Authors:  Spyridon Stavrou; Wenming Zhao; Kristin Blouch; Susan R Ross
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

5.  Full-Length Glycosylated Gag of Murine Leukemia Virus Can Associate with the Viral Envelope as a Type I Integral Membrane Protein.

Authors:  Tyler Milston Renner; Kasandra Bélanger; Cindy Lam; María Carla Rosales Gerpe; Joanne Eileen McBane; Marc-André Langlois
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

6.  The glycosylated Gag protein of a murine leukemia virus inhibits the antiretroviral function of APOBEC3.

Authors:  Angelo Kolokithas; Kyle Rosenke; Frank Malik; Duncan Hendrick; Lukas Swanson; Mario L Santiago; John L Portis; Kim J Hasenkrug; Leonard H Evans
Journal:  J Virol       Date:  2010-08-11       Impact factor: 5.103

7.  Mutation in the glycosylated gag protein of murine leukemia virus results in reduced in vivo infectivity and a novel defect in viral budding or release.

Authors:  Audrey Low; Shoibal Datta; Yurii Kuznetsov; Sohail Jahid; Nayantara Kothari; Alexander McPherson; Hung Fan
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

8.  N-linked glycosylation protects gammaretroviruses against deamination by APOBEC3 proteins.

Authors:  María Carla Rosales Gerpe; Tyler Milston Renner; Kasandra Bélanger; Cindy Lam; Halil Aydin; Marc-André Langlois
Journal:  J Virol       Date:  2014-12-10       Impact factor: 5.103

9.  Blockade of type I interferon (IFN) production by retroviral replicating vectors and reduced tumor cell responses to IFN likely contribute to tumor selectivity.

Authors:  Amy H Lin; Cindy Burrascano; Par L Pettersson; Carlos E Ibañez; Harry E Gruber; Douglas J Jolly
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

10.  Murine leukemia virus glycosylated Gag blocks apolipoprotein B editing complex 3 and cytosolic sensor access to the reverse transcription complex.

Authors:  Spyridon Stavrou; Takayuki Nitta; Swathi Kotla; Dat Ha; Kunio Nagashima; Alan R Rein; Hung Fan; Susan R Ross
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.